Compared to expression of phospho-Akt-Thr308 in control mammary carcinomas (Figure 8A), the number of positive cells and their staining intensity was markedly lower in mammary carcinomas of mice treated with 20 mg/kg/day α-mangostin (Figure 8B). This evidence concerns the gene AKT1 and breast carcinoma.